Suven Life Sciences gets neuro patent from India, Japan
Suven Life Sciences has been granted a patent each by India and Japan for a drug used in the treatment of neuro-degenerative diseases25-09-2017
25-09-2017
Press Release / Media Release
'Suven Life Sciences secures Product Patents in India and Japan'25-09-2017
Suven gets product patent for CNS molecules
Suven Life Sciences has secured a product patent in Japan to be used for developing therapeutic agents that are useful in the treatment of neuro-degenerative diseases. Suven Life said in a BSE...21-08-2017
Suven Life bags process patents for NCEs
Suven Life Sciences on Thursday informed the exchanges that it has secured process patents from Europe, Japan and New Zealand for new chemical entities (NCEs) used for the treatment of disorders...17-08-2017
Press Release / Media Release
Suven Life Sciences secures Process Patents in Europe, Japan and New Zealand17-08-2017
Press Release / Media Release
Suven's Income at Rs. 1466 Mn; PAT at Rs. 295 Mn for the quarter ended June 201714-08-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here14-08-2017
Notification Of Un-Audited Financial Results For The Quarter Ended 30Th June, 2017
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 14th August, 2017, has taken on record the Standalone Un-audited Financial Results of the Company under Ind AS for the quarter ended 30th June, 2017....14-08-2017